YONKERS, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), ...
Given together, two medications unexpectedly improved the clearance of mucus from the lungs of animals. Stanford Medicine researchers will test them in people.